OGEN logo

Oragenics (OGEN) EBITDA

Annual EBITDA

-$20.60 M
-$6.37 M-44.76%

December 31, 2023

Summary

Performance

1-Year Change

-44.76%

3-Year Change

+21.88%

5-Year Change

-108.52%

15-Year Change

-219.38%

OGEN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.13%
OGEN annual EBITDA is higher than 52.13% of companies in Healthcare sector

High & Low

All-time High

-$1.66 M

3-Year Low

-$20.60 M
OGEN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OGEN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 15, 2025
OGEN next annual earnings announcement is scheduled for May 15, 2025

OtherOGENprofitabilitymetrics:

Annual Revenue

-
OGEN annual revenue value is unknown

Annual Net Income

-$20.66 M
OGEN annual net profit is -$20.66 million

Annual EBIT

-$20.63 M
OGEN annual earnings before interest & taxes is -$20.63 million

Annual EPS

-$9.18
OGEN annual earnings per share is -$9.18

Quarterly EBITDA

-$2.45 M
-$149.60 K-6.50%

September 30, 2024

Summary

Performance

3-Month Change

-6.5%

1-Year Change

+80.74%

3-Year Change

+80.74%

5-Year Change

+80.74%

OGEN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.75%
OGEN quarterly EBITDA is higher than 59.75% of companies in Healthcare sector

High & Low

All-time High

$927.90 K
OGEN quarterly EBITDA is currently -364.35% below its historical high of $927.90 thousand

3-Year Low

-$12.74 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OGEN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
OGEN next earnings announcement is scheduled for May 15, 2025

OtherOGENprofitabilitymetrics:

Quarterly Revenue

-
OGEN quarterly revenue value is unknown

Quarterly Net Income

-$2.46 M
OGEN quarterly net profit is -$2.46 million

Quarterly EBIT

-$2.45 M
OGEN quarterly earnings before interest & taxes is -$2.45 million

Quarterly EPS

-$0.38
OGEN quarterly earnings per share is -$0.38

TTM EBITDA

-$19.94 M
-$459.00 K-2.36%

September 30, 2024

Summary

Performance

3-Month Change

-2.36%

1-Year Change

+3.22%

3-Year Change

+3.22%

5-Year Change

+3.22%

OGEN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.25%
OGEN TTM EBITDA is higher than 50.25% of companies in Healthcare sector

High & Low

All-time High

-$205.40 K

3-Year Low

-$20.60 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OGEN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 15, 2025
OGEN next earnings announcement is scheduled for May 15, 2025

OtherOGENprofitabilitymetrics:

TTM Revenue

-
OGEN TTM revenue value is unknown

TTM Net Income

-$19.97 M
OGEN TTM net profit is -$19.97 million

TTM EBIT

-$19.94 M
OGEN TTM earnings before interest & taxes is -$19.94 million

TTM EPS

-$7.07
OGEN TTM earnings per share is -$7.07

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$20.60 M
OGEN annual EBITDA is -$20.60 million

Annual Net Income

-$20.66 M
OGEN annual net profit is -$20.66 million

Annual Interest Expense

$30.60 K
OGEN annual interest expense is $30.60 thousand

Annual Income Tax

$0.00
OGEN annual income tax is $0.00

Annual D&A

$27.40 K
OGEN annual depreciation & amortization is $27.40 thousand

OGEN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.8%+80.7%+3.2%
3 y3 years+21.9%+80.7%+3.2%
5 y5 years-108.5%+80.7%+3.2%

OGEN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-44.8%at low-23.0%+80.7%-97.7%+3.2%
5 y5-year-44.8%+21.9%-23.0%+80.7%-97.7%+24.5%
alltimeall time-1144.3%+21.9%-364.4%+80.7%-9605.5%+24.5%

Oragenics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.45 M(+6.5%)
-$19.94 M(+2.4%)
Jun 2024
-
-$2.30 M(-5.7%)
-$19.48 M(-3.6%)
Mar 2024
-
-$2.44 M(-80.8%)
-$20.21 M(-1.9%)
Dec 2023
-$20.60 M(+44.8%)
-$12.74 M(+538.7%)
-$20.60 M(+104.3%)
Sep 2023
-
-$1.99 M(-34.4%)
-$10.08 M(-15.6%)
Jun 2023
-
-$3.04 M(+7.4%)
-$11.94 M(-4.3%)
Mar 2023
-
-$2.83 M(+27.5%)
-$12.48 M(-12.3%)
Dec 2022
-$14.23 M(-9.1%)
-$2.22 M(-42.4%)
-$14.23 M(-0.4%)
Sep 2022
-
-$3.85 M(+7.7%)
-$14.29 M(-3.5%)
Jun 2022
-
-$3.58 M(-21.9%)
-$14.81 M(-1.5%)
Mar 2022
-
-$4.58 M(+100.7%)
-$15.03 M(-4.0%)
Dec 2021
-$15.65 M(-40.6%)
-$2.28 M(-47.8%)
-$15.65 M(-11.9%)
Sep 2021
-
-$4.37 M(+14.9%)
-$17.77 M(-0.6%)
Jun 2021
-
-$3.80 M(-27.0%)
-$17.88 M(-32.3%)
Mar 2021
-
-$5.20 M(+18.5%)
-$26.40 M(+0.1%)
Dec 2020
-$26.37 M(+70.2%)
-$4.39 M(-2.0%)
-$26.37 M(+3.2%)
Sep 2020
-
-$4.48 M(-63.6%)
-$25.55 M(+2.7%)
Jun 2020
-
-$12.32 M(+138.2%)
-$24.89 M(+43.4%)
Mar 2020
-
-$5.17 M(+44.6%)
-$17.36 M(+12.0%)
Dec 2019
-$15.50 M(+56.9%)
-$3.58 M(-6.3%)
-$15.50 M(+5.7%)
Sep 2019
-
-$3.82 M(-20.4%)
-$14.66 M(+7.9%)
Jun 2019
-
-$4.79 M(+44.7%)
-$13.59 M(+22.7%)
Mar 2019
-
-$3.31 M(+20.8%)
-$11.08 M(+12.2%)
Dec 2018
-$9.88 M(+53.2%)
-$2.74 M(-0.2%)
-$9.88 M(+15.8%)
Sep 2018
-
-$2.75 M(+20.7%)
-$8.53 M(+10.4%)
Jun 2018
-
-$2.28 M(+7.9%)
-$7.73 M(+17.2%)
Mar 2018
-
-$2.11 M(+51.2%)
-$6.60 M(+2.3%)
Dec 2017
-$6.45 M(-23.4%)
-$1.40 M(-28.2%)
-$6.45 M(-16.4%)
Sep 2017
-
-$1.94 M(+69.7%)
-$7.72 M(-0.5%)
Jun 2017
-
-$1.15 M(-41.7%)
-$7.76 M(-6.8%)
Mar 2017
-
-$1.96 M(-26.3%)
-$8.33 M(-1.1%)
Dec 2016
-$8.42 M(-28.0%)
-$2.66 M(+34.2%)
-$8.42 M(+6.2%)
Sep 2016
-
-$1.99 M(+15.8%)
-$7.93 M(+1.9%)
Jun 2016
-
-$1.71 M(-16.6%)
-$7.78 M(-37.2%)
Mar 2016
-
-$2.05 M(-5.5%)
-$12.39 M(+6.7%)
Dec 2015
-$11.69 M(+103.1%)
-$2.17 M(+18.1%)
-$11.61 M(+9.0%)
Sep 2015
-
-$1.84 M(-70.9%)
-$10.65 M(+8.3%)
Jun 2015
-
-$6.32 M(+394.5%)
-$9.84 M(+82.1%)
Mar 2015
-
-$1.28 M(+5.2%)
-$5.40 M(-6.2%)
Dec 2014
-$5.76 M(-64.0%)
-$1.21 M(+18.9%)
-$5.76 M(-24.2%)
Sep 2014
-
-$1.02 M(-45.9%)
-$7.60 M(-52.2%)
Jun 2014
-
-$1.89 M(+15.5%)
-$15.88 M(-1.0%)
Mar 2014
-
-$1.63 M(-46.5%)
-$16.04 M(+0.4%)
DateAnnualQuarterlyTTM
Dec 2013
-$15.97 M(+29.2%)
-$3.05 M(-67.2%)
-$15.97 M(+7.3%)
Sep 2013
-
-$9.30 M(+353.3%)
-$14.89 M(+94.1%)
Jun 2013
-
-$2.05 M(+30.9%)
-$7.67 M(-38.5%)
Mar 2013
-
-$1.57 M(-20.3%)
-$12.47 M(+0.9%)
Dec 2012
-$12.36 M(+70.1%)
-$1.97 M(-5.4%)
-$12.36 M(+1.4%)
Sep 2012
-
-$2.08 M(-69.6%)
-$12.19 M(+3.3%)
Jun 2012
-
-$6.85 M(+369.5%)
-$11.80 M(+63.1%)
Mar 2012
-
-$1.46 M(-18.7%)
-$7.23 M(-0.5%)
Dec 2011
-$7.27 M(-14.1%)
-$1.80 M(+6.2%)
-$7.27 M(-12.8%)
Sep 2011
-
-$1.69 M(-26.0%)
-$8.33 M(-2.1%)
Jun 2011
-
-$2.29 M(+52.9%)
-$8.51 M(+3.4%)
Mar 2011
-
-$1.50 M(-47.8%)
-$8.23 M(-2.8%)
Dec 2010
-$8.46 M(+61.6%)
-$2.86 M(+53.3%)
-$8.46 M(+24.9%)
Sep 2010
-
-$1.87 M(-6.9%)
-$6.77 M(+8.2%)
Jun 2010
-
-$2.00 M(+15.9%)
-$6.26 M(+24.0%)
Mar 2010
-
-$1.73 M(+47.4%)
-$5.05 M(-3.5%)
Dec 2009
-$5.24 M(-9.1%)
-$1.17 M(-13.4%)
-$5.24 M(-24.6%)
Sep 2009
-
-$1.36 M(+71.0%)
-$6.94 M(+4.0%)
Jun 2009
-
-$792.30 K(-58.6%)
-$6.68 M(-3.7%)
Mar 2009
-
-$1.91 M(-33.6%)
-$6.93 M(+20.4%)
Dec 2008
-$5.76 M(+182.5%)
-$2.88 M(+164.9%)
-$5.76 M(+65.8%)
Sep 2008
-
-$1.09 M(+3.8%)
-$3.47 M(+23.5%)
Jun 2008
-
-$1.05 M(+42.0%)
-$2.81 M(+22.8%)
Mar 2008
-
-$738.40 K(+23.6%)
-$2.29 M(+12.6%)
Dec 2007
-$2.04 M(-24.0%)
-$597.30 K(+39.8%)
-$2.03 M(-2.8%)
Sep 2007
-
-$427.20 K(-19.0%)
-$2.09 M(-3.3%)
Jun 2007
-
-$527.50 K(+9.5%)
-$2.16 M(-8.6%)
Mar 2007
-
-$481.80 K(-26.7%)
-$2.37 M(-11.7%)
Dec 2006
-$2.68 M(-10.7%)
-$656.90 K(+31.8%)
-$2.68 M(-1.1%)
Sep 2006
-
-$498.40 K(-31.8%)
-$2.71 M(-6.3%)
Jun 2006
-
-$731.20 K(-8.0%)
-$2.89 M(-2.5%)
Mar 2006
-
-$794.40 K(+15.6%)
-$2.97 M(+138.3%)
Dec 2005
-$3.00 M(-2.6%)
-$687.40 K(+1.2%)
-$1.25 M(-31.1%)
Sep 2005
-
-$679.30 K(-15.8%)
-$1.81 M(+3.4%)
Jun 2005
-
-$806.40 K(-186.9%)
-$1.75 M(+8.2%)
Mar 2005
-
$927.90 K(-174.3%)
-$1.62 M(-19.0%)
Dec 2004
-$3.08 M(+86.2%)
-$1.25 M(+101.3%)
-$1.99 M(+45.5%)
Sep 2004
-
-$620.60 K(-7.9%)
-$1.37 M(+19.7%)
Jun 2004
-
-$673.80 K(-222.6%)
-$1.14 M(+27.1%)
Mar 2004
-
$549.60 K(-187.9%)
-$900.30 K(-45.6%)
Dec 2003
-$1.66 M
-$625.20 K(+58.3%)
-$1.66 M(+60.7%)
Sep 2003
-
-$394.90 K(-8.1%)
-$1.03 M(+62.2%)
Jun 2003
-
-$429.80 K(+109.3%)
-$635.20 K(+209.3%)
Mar 2003
-
-$205.40 K
-$205.40 K

FAQ

  • What is Oragenics annual EBITDA?
  • What is the all time high annual EBITDA for Oragenics?
  • What is Oragenics annual EBITDA year-on-year change?
  • What is Oragenics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Oragenics?
  • What is Oragenics quarterly EBITDA year-on-year change?
  • What is Oragenics TTM EBITDA?
  • What is the all time high TTM EBITDA for Oragenics?
  • What is Oragenics TTM EBITDA year-on-year change?

What is Oragenics annual EBITDA?

The current annual EBITDA of OGEN is -$20.60 M

What is the all time high annual EBITDA for Oragenics?

Oragenics all-time high annual EBITDA is -$1.66 M

What is Oragenics annual EBITDA year-on-year change?

Over the past year, OGEN annual EBITDA has changed by -$6.37 M (-44.76%)

What is Oragenics quarterly EBITDA?

The current quarterly EBITDA of OGEN is -$2.45 M

What is the all time high quarterly EBITDA for Oragenics?

Oragenics all-time high quarterly EBITDA is $927.90 K

What is Oragenics quarterly EBITDA year-on-year change?

Over the past year, OGEN quarterly EBITDA has changed by +$10.28 M (+80.74%)

What is Oragenics TTM EBITDA?

The current TTM EBITDA of OGEN is -$19.94 M

What is the all time high TTM EBITDA for Oragenics?

Oragenics all-time high TTM EBITDA is -$205.40 K

What is Oragenics TTM EBITDA year-on-year change?

Over the past year, OGEN TTM EBITDA has changed by +$662.60 K (+3.22%)